Laden…
Substance Comparison
Etizolam stands out with markedly stronger sedation. In terms of addiction risk, Etizolam scores notably higher.
Despite belonging to different classes, these substances share receptor activity at GABA-A, which may produce overlapping effects.
Etizolam has significantly higher sedation
Etizolam has notably higher addiction risk
| Bromazolam | Etizolam | |
|---|---|---|
| Class | Benzodiazepine | Depressiva |
| Risk Level | high | high |
| Mechanisms | Positive allosterische Modulation am GABA-A-Rezeptor, benzodiazepinartig, Verstaerkung inhibitorischer GABAerger Signalgebung mit Sedierung, Amnesie und Ataxie, Humanpharmakokinetik und Tablettenstaerken sind im nicht regulierten Markt unsicher | GABA-A positive allosterische Modulation |
| Receptors | GABA-A | GABA-A |
| Effects | Sedierung, Schlaefrigkeit und Angstloesung, Anterograde Amnesie und Blackouts, Enthemmung und reduzierte Urteilsfaehigkeit, Ataxie, verwaschene Sprache und Sturz-/Unfallrisiko, Atemdepression vor allem bei Kombination mit anderen Downern | — |
| Evidence | moderate | unknown |
GABA-A agonist
Safer-use data available on substance page
Safer-use data available on substance page
Evidence: moderate · Sources: 6
Evidence: unknown · Sources: 3